I think BD1 has sucked a lot of the momentum from biotech stocks. But between BD1 and BIT, I think MEM has the most promise. We're literally on stage 4 clinical trials, and given the people that the organization has chosen for stage 4 trials, I'm pretty sure their confident that there's going to be positive feedback. worth at least 20 cents a share. I guess MEM isn't as sexy as the other biotech's, being to do with isolating sperm cells. Which is ironic.
I think BD1 has sucked a lot of the momentum from biotech...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.00M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 6639600 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 11066843 | 9 |
View Market Depth
| Last trade - 07.01am 29/11/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
Day chart unavailable
